Metacrine, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTCR research report →
Companywww.metacrine.com
Metacrine, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis.
- CEO
- David M. Maggio
- IPO
- 2020
- Employees
- 10
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- -0.40
- P/S
- 0.00
- P/B
- 0.43
- EV/EBITDA
- 1.04
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -83.52%
- ROIC
- -82.30%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-61,235,000 · -68.35%
- EPS
- $-1.45 · 62.53%
- Op Income
- $-61,079,000
- FCF YoY
- -29.52%
Performance & Tape
- 52W High
- $0.59
- 52W Low
- $0.30
- 50D MA
- $0.56
- 200D MA
- $0.49
- Beta
- -0.74
- Avg Volume
- 52.47K
Get TickerSpark's AI analysis on MTCR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 23, 23 | Klassen Preston | other | 842,211 |
| Mar 23, 23 | Klassen Preston | sell | 842,211 |
| Jan 26, 23 | York Michael | sell | 107,054 |
| Jan 26, 23 | Klassen Preston | sell | 380,605 |
| Dec 21, 22 | Leonard Braden Michael | buy | 120,099 |
| Dec 20, 22 | Leonard Braden Michael | buy | 50,122 |
| Dec 19, 22 | Leonard Braden Michael | buy | 101,384 |
| Nov 9, 22 | Leonard Braden Michael | buy | 39,816 |
| Nov 8, 22 | Leonard Braden Michael | buy | 500 |
| Nov 7, 22 | Leonard Braden Michael | buy | 123,954 |
Our MTCR Coverage
We haven't published any research on MTCR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MTCR Report →